Complete Genomics Delays Start of Commercial Operations to Q2; Cuts Target to 5,000 Genomes in 2010
January 19, 2010
Complete Genomics Delays Start of Commercial Operations to Q2; Cuts Target to 5,000 Genomes in 2010
The company's genome center will be "fully operational and running at capacity" at the beginning of April, at which point Complete Genomics expects to be able to sequence 10,000 human genomes over the following 12 months, with half of those to be completed by the end of 2010.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Complete Genomics Signs Two Contracts Worth $14M as Falling Prices Impact Q2 Revenues
August 9, 2011 / In Sequence - Complete Genomics Nears Commercial Launch; Eyes Thousands of Genomes in 2010
January 14, 2010 / GenomeWeb Daily News - Complete Genomics Sees Future in Cancer Genome Sequencing; Plans New Cancer-Specific Product
March 16, 2011 / Clinical Sequencing News - Two Studies Highlight Ability of Whole-Genome Sequencing to ID Causative Genes in Mendelian Disease
March 16, 2010 / In Sequence - Complete Genomics Aims for Positive Cash Flow by Mid-2010; Position Itself for IPO
December 8, 2009 / In Sequence